SCHEMBL6943976

SCHEMBL6943976

N#Cc1cc(Cl)c(Cl)cc1CBr

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.36
MAPK1 P28482 1/20 0.33
PGK1 P00558 1/20 0.33
VCAM1 P19320 1/20 0.32
SNCA P37840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585046 0.84 SNCA (0.35) TRPV4SNCA
SCHEMBL8385538 0.77 VCAM1 (0.47) MAPK1PGK1VCAM1
SCHEMBL522162 0.75 TRPV4 (0.48) TRPV4MAPK1PGK1VCAM1
SCHEMBL29827885 0.75 TRPV4 (0.48) TRPV4MAPK1PGK1VCAM1
SCHEMBL3311060 0.75 AHR (0.35) MAPK1
SCHEMBL29472350 0.75 AHR (0.35) MAPK1
SCHEMBL584071 0.75 NOS2 (0.48) VCAM1
SCHEMBL2451732 0.75 CYP2A6 (0.41) MAPK1VCAM1
SCHEMBL20041911 0.74 TRPV4 (0.42) TRPV4SNCA
SCHEMBL6990236 0.72 TSHR (0.35) SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178802-A4 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS MERCK & CO INC (US) 2003-06-04 EP disclosed
US-6376530-B1 A N-METHYLASPARTIC ACID ANTAGONIST; NERVOUS SYSTEM DISORDERS, ANALGESICS MERCK & CO., INC. 2002-04-23 US disclosed
EP-1178802-A1 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-02-13 EP disclosed
WO-2000067755-A1 CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS MERCK & CO., INC. (US) 2000-11-16 WO disclosed